Breaking News

3P Biopharmaceuticals Increases Microbial Production Capacity

Installs a 500 L fermenter for manufacturing biological medicinal products.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

3P Biopharmaceuticals, a contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing for biological products, has installed a new 500-liter stainless steel fermenter to complement its existing capacity for protein production from bacteria and yeast with fermentation technology. The addition of this new capacity complements the existing three fermentation lines that carry out drug production from bacteria and yeast. This means that 3P B...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters